Cell-based therapies present enormous opportunities to improve the lives of patients suffering from a number of diseases. One example is CAR T-cell therapies, which re-engineer a patient’s immune cells, and have shown impressive response rates in certain blood cancers. But there is a tremendous unmet demand for personalized cell therapies to treat degenerative diseases — diseases in which time is the body’s enemy, for which we need a way to turn back or slow down the clock.

I cannot overstate the excitement and energy at Cellino — the sheer force of creativity expanding the frontier of the possible. Prior to…

Arnaldo E. Pereira

AI/ML lead @Cellino. Believer in AI for good. Decision-making under uncertainty. Reformed ex-lawyer.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store